drugset / Trial / NCT01320176

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

NCT01320176 ↗

Phase 1 Completed 36 enrolled Institut Pasteur
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This study aimed to evaluate the safety and reactogenicity of two intramuscular injections of two different dosages of an investigational clade B HIV vaccine.

Timeline

Start
2010-10
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Recombinant HIV I Clade B Measles Vaccine Vector Vaccine 2.9 unknown Intramuscular
Subject Recombinant HIV I Clade B Measles Vaccine Vector Vaccine 4 unknown Intramuscular